306 related articles for article (PubMed ID: 12679912)
1. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.
Huang XH; Sun LH; Lu DD; Sun Y; Ma LJ; Zhang XR; Huang J; Yu L
World J Gastroenterol; 2003 Apr; 9(4):692-5. PubMed ID: 12679912
[TBL] [Abstract][Full Text] [Related]
2. Plasma 249Ser p53 mutation in patients with hepatocellular carcinoma residing in a high risk area.
Dong-Dong L; Xi-Ran Z
J Cell Mol Med; 2003; 7(1):89-92. PubMed ID: 12767266
[TBL] [Abstract][Full Text] [Related]
3. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
[TBL] [Abstract][Full Text] [Related]
4. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia.
Kirk GD; Camus-Randon AM; Mendy M; Goedert JJ; Merle P; Trépo C; Bréchot C; Hainaut P; Montesano R
J Natl Cancer Inst; 2000 Jan; 92(2):148-53. PubMed ID: 10639517
[TBL] [Abstract][Full Text] [Related]
5. Mutational hotspot in the p53 gene in human hepatocellular carcinomas.
Hsu IC; Metcalf RA; Sun T; Welsh JA; Wang NJ; Harris CC
Nature; 1991 Apr; 350(6317):427-8. PubMed ID: 1849234
[TBL] [Abstract][Full Text] [Related]
6. Mutations at codon 249 of p53 gene in human hepatocellular carcinomas from Tongan, China.
Yang M; Zhou H; Kong RY; Fong WF; Ren LQ; Liao XH; Wang Y; Zhuang W; Yang S
Mutat Res; 1997 Nov; 381(1):25-9. PubMed ID: 9403027
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
[TBL] [Abstract][Full Text] [Related]
8. [Universal presence of HBVx gene and its close association with hotspot mutation of p53 gene in hepatocellular carcinoma of prevalent area in China].
Zhang F; Zhu Y; Sun Z
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):18-21. PubMed ID: 10921048
[TBL] [Abstract][Full Text] [Related]
9. Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients.
Jackson PE; Kuang SY; Wang JB; Strickland PT; Muñoz A; Kensler TW; Qian GS; Groopman JD
Carcinogenesis; 2003 Oct; 24(10):1657-63. PubMed ID: 12869416
[TBL] [Abstract][Full Text] [Related]
10. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
11. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
[TBL] [Abstract][Full Text] [Related]
12. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
Liu H; Wang Y; Zhou Q; Gui SY; Li X
World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
[TBL] [Abstract][Full Text] [Related]
13. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma.
Goldblum JR; Bartos RE; Carr KA; Frank TS
Am J Surg Pathol; 1993 Dec; 17(12):1244-51. PubMed ID: 8238731
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of high frequency 249 codon mutation of p53 gene in hepatocellular carcinoma in prevalent area of China].
Ming L; Yuan B; Thorgeirsson SS
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):122-4. PubMed ID: 11776852
[TBL] [Abstract][Full Text] [Related]
16. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
[TBL] [Abstract][Full Text] [Related]
17. Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa.
Szymańska K; Lesi OA; Kirk GD; Sam O; Taniere P; Scoazec JY; Mendy M; Friesen MD; Whittle H; Montesano R; Hainaut P
Int J Cancer; 2004 Jun; 110(3):374-9. PubMed ID: 15095302
[TBL] [Abstract][Full Text] [Related]
18. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
[TBL] [Abstract][Full Text] [Related]
19. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
Shieh YS; Nguyen C; Vocal MV; Chu HW
Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
[TBL] [Abstract][Full Text] [Related]
20. [Sequence alterations in p53 gene of hepatocellular carcinoma from high aflatoxin risk area in Guangxi].
Deng Z; Pan L; Ma Y
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):18-21. PubMed ID: 10743047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]